Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

   136,880,248      
Direct Value   $2,269,142,219    

Indirect Value

   $6,799,584,333      
Total Shares   186,710,189      
Total Value   $9,068,726,552      


Neurocrine Biosciences Inc $685,586,378 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $47,965,920 Ligand Pharmaceuticals Inc $1,070,543,372 Curis Inc $3,390,252 Repligen Corp $460,602,029 Gyre Therapeutics $1,054,262 Neurocrine Biosciences Inc $685,586,378 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $47,965,920 Ligand Pharmaceuticals Inc $1,070,543,372 Curis Inc $3,390,252 Repligen Corp $460,602,029 Gyre Therapeutics $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    19   
    2    

     Stock price went up :
    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-04-12 4 S $2.80 $291,398 D/D (104,000) 5,041,447 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-04-09 4 S $2.76 $259,290 D/D (94,000) 5,145,447 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-31 4 S $2.70 $2,700 D/D (1,000) 5,239,447 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-30 4 S $2.70 $280,852 D/D (104,000) 5,240,447 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-29 4 S $2.70 $208,347 D/D (77,100) 5,344,447 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-26 4 S $2.70 $84,249 D/D (31,200) 5,421,547 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-25 4 S $2.70 $822,960 D/D (304,800) 5,452,747 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-24 4 S $2.75 $242,334 D/D (88,000) 5,757,547 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-23 4 S $2.75 $79,750 D/D (29,000) 5,845,547 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-22 4 S $2.77 $199,397 D/D (72,000) 5,874,547 0 -
EPRS Epirus Biopharmaceuticals... Direct Beneficial Owner   –       –       •   2009-12-22 4 S $0.80 $2,542,319 D/D (3,177,899) 6,830,972 0 -
NTII Neurobiological Technolog... Direct Beneficial Owner   –       –       •   2009-10-21 4 S $0.91 $4,191,819 D/D (4,606,395) 331,998 0 -
GYRE Gyre Therapeutics Indirect Beneficial Owner   –       –       •   2009-10-16 4 S $23.60 $15,063,112 D/D (638,400) 2,061,925 0 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-09-10 4 S $2.76 $3,350,988 D/D (1,212,106) 4,278,851 0 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-08-06 4 S $2.03 $7,103 D/D (3,500) 5,490,957 0 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-08-05 4 S $2.00 $793,624 D/D (396,000) 5,494,457 0 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-07-30 4 S $1.85 $28,907 D/D (15,600) 5,890,457 0 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-07-29 4 S $1.85 $210,350 D/D (113,500) 5,906,057 0 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-07-28 4 S $1.85 $90,665 D/D (49,000) 6,019,557 0 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-07-27 4 S $1.99 $488,215 D/D (245,100) 6,068,557 0 -
GYRE Gyre Therapeutics Direct Beneficial Owner   –       –       •   2009-07-14 4 B $2.99 $28,492 D/D 9,516 2,700,325 2.37 -
GYRE Gyre Therapeutics Direct Beneficial Owner   –       –       •   2009-07-13 4 B $2.89 $6,361 D/D 2,200 2,690,809 2.37 -
GYRE Gyre Therapeutics Direct Beneficial Owner   –       –       •   2009-07-10 4 B $2.79 $5,578 D/D 2,000 2,688,609 2.37 -
GYRE Gyre Therapeutics Direct Beneficial Owner   –       –       •   2009-07-09 4 B $3.10 $66,646 D/D 21,500 2,686,609 2.45 -
RGEN Repligen Corp Indirect Beneficial Owner   –       –       •   2009-07-07 4 S $5.50 $5,500 D/D (1,000) 2,765,050 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us